Spontaneous Resolution of Primary Hyperparathyroidism in Parathyroid Adenoma

Por Micale, Sara J., Kane, Michael P., Busch, Robert S.
Publicado em 2012

Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus

Por Micale, Sara J., Kane, Michael P., Hogan, Eileen
Publicado em 2013

A real‐world, observational study of weekly exenatide added to basal insulin in patients with type 2 diabetes mellitus (NCT02895672)

Por Stryker, Matthew D., Kane, Michael P., Busch, Robert S.
Publicado no Endocrinol Diabetes Metab (2017)

No Postoperative Adrenal Insufficiency in a Patient with Unilateral Cortisol-Secreting Adenomas Treated with Mifepristone Before Surgery

Por Saroka, Rachel M., Kane, Michael P., Robinson, Lawrence, Busch, Robert S.
Publicado no Clin Med Insights Endocrinol Diabetes (2016)

Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists

Por Kane, Michael P, Triplitt, Curtis L, Solis-Herrera, Carolina D
Publicado no Am J Health Syst Pharm (2020)

Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy

Por Rehman, Hasan, Silk, Ann W., Kane, Michael P., Kaufman, Howard L.
Publicado no J Immunother Cancer (2016)

Method for Simultaneous Determination of Free Concentration, Total Concentration, and Plasma Binding Capacity in Clinical Samples

Por Cibotaru, Dorina, Celestin, Marie N., Kane, Michael P., Musteata, Florin M.
Publicado no J Pharm Sci (2020)

A Clinical Perspective of Canagliflozin in the Management of Type 2 Diabetes Mellitus

Por Nardolillo, AnneMarie, Kane, Michael P, Busch, Robert S, Watsky, Jay, Hamilton, Robert A
Publicado em 2014

Weekly Exenatide Therapy: A Real-World Comparison of Incretin Therapies

Por Micale, Sara J., Khatounabadi, Shahabodin, Kane, Michael P., Busch, Robert S., Bakst, Gary, Abelseth, Jill M., Hamilton, Robert A.
Publicado no J Pharm Technol (2014)

Next Generation Sequencing As an Aid to Diagnosis and Treatment of an Unusual Pediatric Brain Cancer

Por Glod, John, Song, Mihae, Sharma, Archana, Tyagi, Rachana, Rhodes, Roy H., Weissmann, David J., Roychowdhury, Sudipta, Khan, Atif, Kane, Michael P., Hirshfield, Kim, Ganesan, Shridar, DiPaola, Robert S., Rodriguez-Rodriguez, Lorna
Publicado no J Pers Med (2014)

Phase I trial of selenium plus chemotherapy in gynecologic cancers

Por Song, Mihae, Kumaran, Muthu N., Gounder, Murugesan, Gibbon, Darlene G., Nieves-Neira, Wilberto, Vaidya, Ami, Hellmann, Mira, Kane, Michael P., Buckley, Brian, Shih, Weichung, Caffrey, Paula B., Frenkel, Gerald D., Rodriguez-Rodriguez, Lorna
Publicado no Gynecol Oncol (2018)

High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma

Por Silk, Ann W., Kaufman, Howard L., Curti, Brendan, Mehnert, Janice M., Margolin, Kim, McDermott, David, Clark, Joseph, Newman, Jenna, Bommareddy, Praveen K., Denzin, Lisa, Najmi, Saltanat, Haider, Azra, Shih, Weichung, Kane, Michael P., Zloza, Andrew
Publicado no Front Oncol (2020)

Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer

Por Newman, Jenna H., Chesson, C. Brent, Herzog, Nora L., Bommareddy, Praveen K., Aspromonte, Salvatore M., Pepe, Russell, Estupinian, Ricardo, Aboelatta, Mones M., Buddhadev, Stuti, Tarabichi, Saeed, Lee, Michael, Li, Shengguo, Medina, Daniel J., Giurini, Eileena F., Gupta, Kajal H., Guevara-Aleman, Gabriel, Rossi, Marco, Nowicki, Christina, Abed, Abdulkareem, Goldufsky, Josef W., Broucek, Joseph R., Redondo, Raquel E., Rotter, David, Jhawar, Sachin R., Wang, Shang-Jui, Kohlhapp, Frederick J., Kaufman, Howard L., Thomas, Paul G., Gupta, Vineet, Kuzel, Timothy M., Reiser, Jochen, Paras, Joyce, Kane, Michael P., Singer, Eric A., Malhotra, Jyoti, Denzin, Lisa K., Sant’Angelo, Derek B., Rabson, Arnold B., Lee, Leonard Y., Lasfar, Ahmed, Langenfeld, John, Schenkel, Jason M., Fidler, Mary Jo, Ruiz, Emily S., Marzo, Amanda L., Rudra, Jai S., Silk, Ann W., Zloza, Andrew
Publicado no Proc Natl Acad Sci U S A (2020)